Evidence map›Paper›PMID 39582223›Full record

ArticleCurrent neuropharmacology2025

Cafeteria Diet Abstinence Induces Depressive Behavior and Disrupts Endocannabinoid Signaling in Dopaminergic Areas: A Preclinical Study.

Marialuisa de Ceglia, Adele Romano, Maria Vittoria Micioni Di Bonaventura, Ana Gavito, Luca Botticelli, Emanuela Micioni Di Bonaventura, Marzia Friuli, Carlo Cifani, Fernando Rodríguez de Fonseca, Silvana Gaetani

Abstract read
In one paragraph

Article in Current neuropharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marialuisa de CegliaUGC de Salud Mental y Unidad Clínica de Neurología, Grupo de Neuropsicofarmacología, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga-Hospital Universitario Regional de Málaga, 29010 Málaga, Spain.
Adele RomanoDepartment of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.
Maria Vittoria Micioni Di BonaventuraSchool of Pharmacy, Pharmacology Unit, University of Camerino, Camerino, Italy.
Ana GavitoUGC de Salud Mental y Unidad Clínica de Neurología, Grupo de Neuropsicofarmacología, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga-Hospital Universitario Regional de Málaga, 29010 Málaga, Spain.
Luca BotticelliSchool of Pharmacy, Pharmacology Unit, University of Camerino, Camerino, Italy.
Emanuela Micioni Di BonaventuraSchool of Pharmacy, Pharmacology Unit, University of Camerino, Camerino, Italy.
Marzia FriuliDepartment of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.
Carlo CifaniSchool of Pharmacy, Pharmacology Unit, University of Camerino, Camerino, Italy.
Fernando Rodríguez de FonsecaUGC de Salud Mental y Unidad Clínica de Neurología, Grupo de Neuropsicofarmacología, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga-Hospital Universitario Regional de Málaga, 29010 Málaga, Spain.
Silvana GaetaniDepartment of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy.

Funding

Consejería de Salud y Familia, Junta de Andalucía NeuroRECA, RIC-0111-2019Italian Ministry of University and Research 2012JTX3KLItalian Ministry of University and Research (MUR), by the European Union - NextGenerationEU PRIN2022LHMF43, CUP J53D23012220001, PRIN 2022SZ2FMK, CUP J53D23012440006Ministerio de Ciencia e Innovación and European Regional Development Funds-European Union (ERDF-EU) PI22/00427Ministerio de Sanidad, Delegación de Gobierno para el Plan Nacional sobre Drogas PND 2022I020PNRR CUP B83C22002820006, FP7Programa RETICS Red de Trastornos Adictivos RD16/0017/000RICORS RIAPAD (Red de Investigación en Atención Primaria en Adicciones) RD21/009/0003
6 · The paper itself

Abstract

backgroundAlterations of dopamine (DA) transmission in the brain reward system can be associated with an addictive-like state defined as food addiction (FA), common in obese individuals. Subjects affected by FA experience negative feelings when abstinent from their preferred diet and may develop mood disorders, including depression, sustained by alterations in brain DA pathways.

objectiveThis study aims to investigate the impact of long-term abstinence from a palatable diet on depressive-like behavior in rats, exploring neurochemical alterations in monoamine and endocannabinoid signaling in DA-enriched brain regions, including ventral tegmental area, dorsolateral striatum, substantia nigra and medial prefrontal cortex.

methodsRats underwent exposure and subsequent abstinence from a palatable cafeteria diet. During abstinence, animals were treated with fatty acid amide hydrolase (FAAH) inhibitor PF-3845 (10 mg/kg, intraperitoneal administration every other day). Lastly, animals were subjected to a forced swimming test, and their brains were dissected and processed for high-performance liquid chromatography measurement of monoamines and western blot analyses of markers of the endocannabinoid machinery.

resultsAfter the withdrawal from the palatable diet, animals showed depressive-like behavior, coupled with significant variations in the concentration of brain monoamines and in the expression of endocannabinoid signalling machinery proteins in cited brain areas. Treatment with PF-3845 exerted an antidepressant- like effect and restored part of the alterations in monoaminergic and endocannabinoid systems.

conclusionOverall, our results suggest that abstinence from a cafeteria diet provokes emotional disturbances linked to neuroadaptive changes in monoamines and endocannabinoid signalling in brain areas partaking to DA transmission that could partially be restored by the enhancement of endocannabinoid signalling through FAAH inhibition.

Indexed as

BrainDepressionDopamineEndocannabinoidsFood AddictionAmidohydrolasesAnimalsFatty Acid Amide HydrolasesMaleRatsRats, WistarSignal TransductionAmidohydrolasesDopamineEndocannabinoidsFatty Acid Amide Hydrolasesabstinencecafeteria dietdepressiondopamine.endocannabinoid systemfatty acid amide hydrolaseFood addiction

Identifiers

PMID39582223
PMCPMC12105268

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.